Holen Sie sich die Stockscreener-App
9.30
2.31%
0.21
Handel nachbörslich:
9.23
-0.07
-0.75%
Schlusskurs vom Vortag:
$9.09
Offen:
$8.95
24-Stunden-Volumen:
261.42K
Relative Volume:
1.08
Marktkapitalisierung:
$243.21M
Einnahmen:
$47.26M
Nettoeinkommen (Verlust:
$-58.48M
KGV:
-3.4382
EPS:
-2.7049
Netto-Cashflow:
$-40.45M
1W Leistung:
+6.53%
1M Leistung:
+18.17%
6M Leistung:
+42.42%
1J Leistung:
+18.02%
1-Tages-Spanne:
$8.69
$9.655
1-Wochen-Bereich:
$8.50
$9.655
52-Wochen-Spanne:
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
Firmenname
Cvrx Inc
Sektor
Branche
Telefon
(763) 416-2850
Adresse
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Vergleichen Sie CVRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
9.30 | 237.00M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
133.27 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
370.00 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.54 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.36 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Bestätigt | Lake Street | Buy |
| 2024-05-01 | Fortgesetzt | Craig Hallum | Buy |
| 2024-05-01 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Eingeleitet | Lake Street | Buy |
| 2022-07-18 | Eingeleitet | Craig Hallum | Buy |
| 2021-07-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-26 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cvrx Inc Aktie (CVRX) Neueste Nachrichten
What to do if you’re stuck in CVRXWeekly Profit Summary & Stepwise Trade Execution Plans - newser.com
What recovery options are there for CVRXJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com
Is CVRX building a consolidation baseMarket Trend Review & Real-Time Market Sentiment Reports - newser.com
Applying sector rotation models to CVRx Inc.Trade Volume Summary & Free Fast Entry Momentum Trade Alerts - newser.com
What institutional flow reveals about CVRx Inc.Weekly Trading Summary & AI Enhanced Trading Signals - newser.com
How to integrate CVRX into portfolio analysis toolsJuly 2025 Drop Watch & Accurate Buy Signal Alerts - newser.com
Is CVRx Inc. trending in predictive chart modelsRecession Risk & Verified Momentum Watchlists - newser.com
Understanding CVRx Inc.’s price movementJuly 2025 Retail & Daily Stock Trend Reports - newser.com
Will CVRX bounce back from current support2025 Year in Review & Stock Portfolio Risk Control - newser.com
How to manage a losing position in CVRXJuly 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
How sentiment analysis helps forecast CVRXCPI Data & Long-Term Growth Plans - newser.com
Is CVRX stock trading at a premium valuationMarket Performance Recap & High Accuracy Swing Entry Alerts - newser.com
What MACD and RSI say about CVRx Inc.July 2025 Earnings & Verified High Yield Trade Plans - newser.com
How to monitor CVRx Inc. with trend dashboards2025 Market Overview & Smart Investment Allocation Insights - newser.com
CVRx upgraded by William Blair to outperform - MSN
Predicting CVRx Inc. trend using moving averagesJuly 2025 Pullbacks & Capital Efficient Trade Techniques - newser.com
What the charts say about CVRX today2025 Investor Takeaways & Short-Term Trading Alerts - newser.com
Is CVRx Inc. still worth holding after the dipWeekly Gains Summary & Free Technical Pattern Based Buy Signals - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for CVRx (NASDAQ:CVRX) - MarketBeat
Best data tools to analyze CVRX stockJuly 2025 Recap & Reliable Entry Point Trade Alerts - newser.com
Should you hold or exit CVRX now2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
What machine learning models say about CVRx Inc.Market Performance Summary & AI Powered Market Entry Ideas - newser.com
Smart tools for monitoring CVRX’s price actionJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - newser.com
CVRx, Inc. (NASDAQ:CVRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Tick level data insight on CVRx Inc. volatilityPortfolio Value Report & Long Hold Capital Preservation Tips - newser.com
Sentiment analysis tools applied to CVRXBreakout Watch & Real-Time Chart Pattern Alerts - newser.com
Does CVRX qualify in momentum factor screeningJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Real time scanner hits for CVRX explainedQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
Is a relief rally coming for CVRx Inc. holders2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com
Can CVRx Inc. stock resist market sell offsJuly 2025 Sentiment & Verified Momentum Watchlists - newser.com
$CVRX stock is up 11% today. Here's what we see in our data. - Quiver Quantitative
Long term hold vs stop loss in CVRXJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com
How to build a dashboard for CVRX stockGold Moves & High Yield Equity Trading Tips - newser.com
Finanzdaten der Cvrx Inc-Aktie (CVRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cvrx Inc-Aktie (CVRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nielsen Kirk G. | Director |
May 13 '25 |
Buy |
5.29 |
101,413 |
536,313 |
1,837,968 |
| Nielsen Kirk G. | Director |
May 14 '25 |
Buy |
5.23 |
61,200 |
320,364 |
1,899,168 |
| Nielsen Kirk G. | Director |
May 12 '25 |
Buy |
4.79 |
25,200 |
120,670 |
1,736,555 |
| Jain Mudit K. | Director |
May 12 '25 |
Buy |
4.66 |
1,500 |
6,986 |
4,900 |
| Jain Mudit K. | Director |
May 13 '25 |
Buy |
5.26 |
150 |
789 |
5,050 |
| Hykes Kevin | PRES & CEO |
May 12 '25 |
Buy |
4.84 |
5,000 |
24,200 |
133,000 |
1.19%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):